Catestatin as a Target for Treatment of Inflammatory Diseases

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2018.02199
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

NF-κB as a Therapeutic Target in Inflammatory-Associated Bone Diseases

Advances in Protein Chemistry and Structural Biology
BiochemistryStructural Biology
2017English

The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases

Frontiers in Immunology
AllergyImmunology
2016English

Antioxidant Nanotherapies for the Treatment of Inflammatory Diseases

Frontiers in Bioengineering and Biotechnology
BioengineeringBiomedical EngineeringHistologyBiotechnology
2020English

Anti-Inflammatory MicroRNAs and Their Potential for Inflammatory Diseases Treatment

Frontiers in Immunology
AllergyImmunology
2018English

The Gut Microbiota as Target for Innovative Drug Development: Perspectives and a Case Study of Inflammatory Bowel Diseases

2011English

Calprotectin as a Diagnostic Tool for Inflammatory Bowel Diseases

Biomedical Reports
GeneticsPharmacologyMolecular BiologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2016English

Caldesmon as a Therapeutic Target for Proliferative Vascular Diseases

Mini-Reviews in Medicinal Chemistry
MedicineDrug DiscoveryPharmacology
2008English

Ghrelin as a Treatment for Cardiovascular Diseases

Hypertension
Internal Medicine
2014English

Selective PDE4 Inhibitors as Potent Anti-Inflammatory Drugs for the Treatment of Airway Diseases

Memorias do Instituto Oswaldo Cruz
MedicineMicrobiology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy